A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy

NCT07289477 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple System Atrophy - Parkinsonian Subtype (MSA-P)

Interventions

BIOLOGICAL: Human Dopaminergic Progenitor Cells

Sponsor

iRegene Therapeutics Co., Ltd.